Global biosimilars market report gives comprehensive outlook on biosimilars products across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on biosimilars market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, application, manufacturing type, distribution channel, and geographic regions. Global biosimilars market estimated to be valued US$ 4.10 Bn in 2018 and poised to grow at CAGR of 23.0% over 2019-2025. Market for biosimilars projected to reach US$ 14.23 Bn by 2025 owing to increasing patent expires of biologics and rising biosimilars product pipeline.
Major Key Players of the Biosimilars Market are:
Amgen Inc. (U.S.), Biocon Ltd. (India), Celltrion, Inc. (South Korea), Dr Reddy’s Laboratories Ltd. (India), F. Hoffmann-La Roche Ltd. (Switzerland), Pfizer Inc. (U.S.), Samsung Bioepis (South Korea), Novartis AG (Switzerland), Teva Pharmaceuticals Industries Ltd. (Israel)
No comments:
Post a Comment